Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?
Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile and the Recovery of Hemoglobin in Total Knee and Hip Arthroplasty Surgery?
研究概览
详细说明
Participation and recruitment: Patients undergoing elective total knee arthroplasty due to osteoarthritis will be interviewed for participation and recruited after providing written informed consent.
Randomization and group allocation:
All recruited patients will be given patient identification number (PIN) for the present study of 01-77 according to their order of interview and recruitment.
Investigators will prepare 33 yellow and 34 green cards, which will be inserted in 77 thick-paper envelopes. Then, all envelopes will be sealed, mixed and randomly allocated to get numbers of 01 to 77 (Envelop number).
After printing the envelope number outside envelope, all sealed envelopes with cards will be conveyed to and kept in pharmacy department.
Preparation and Administration of study drug:
Pharmacist will open the envelope with the number same to PIN and check the color of the card inside at study on operation day.
According to the color of the card, IV-iron or placebo will be prepared for the patient: IV-iron for yellow card; placebo for green cards, respectively.
The study drug was employed as "open labelled".
IV-iron or placebo will be infused through already established intravenous line within 30 min after anesthesia induction by attending anesthesiologist who is aware of the patient's group-allocation.
Patient data and statistical analyses:
The information regarding the patient's group allocation will be kept in the pharmacy department till the end of the study and conveyed during the data analyses after completion of the 77th patient participation and discharge.
Patient's data PaO2, FiO2, Hb, intra-op and postop-transfusion amount, intraop- and postop-bleeding amount will be determined from the patients' medical record after patient's discharge.
All statistical analyses will be performed after the 77th patient's discharge and data acquisition.
Surgical procedures:
All surgical procedures will be performed using standardized institutional anesthetic and surgical protocols, antibiotic and antithrombotic prophylaxis, transfusion protocols, and post-operative analgesia.
All TKA will be performed using a pneumatic tourniquet, which is deflated after wound closure. Closed suction drains, which are removed on the second post-operative day, will be placed in all operations.
Transfusion protocol:
Following allogenic blood transfusion protocol will be uniformly applied by anesthesiologists and surgeons to all patients in the operating theater, the post-operative anesthesia care unit, and the ward for the entire duration of hospitalization: blood transfusion of packed RBC will not be performed unless patient's Hb level is < 9 g/dL without any signs and/or symptoms of acute anemia such as hypotension, tachycardia, tachypnea, dizziness, and fatigue.
研究类型
注册 (实际的)
阶段
- 第四阶段
联系人和位置
学习地点
-
-
-
Seoul、大韩民国
- Konkuk University Medical Center & Asan Medical Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients with osteoarthritis in knee joint undergoing elective uni-limb total knee arthroplasty surgery
- Patients provided a written informed consent.
- Patients with s-ferritin < 300 mg/dl (male) or 200 mg/dl (female)
- Patients with preoperative serum hemoglobin concentration >10 g/dL
- Patients with PaO2/FiO2 ratio >150
Exclusion Criteria:
- Patients with history of anaphylaxis, iron overload, active infection.
- Patients received or receiving intraoperative and preoperative blood salvaged, allogenic blood transfusion, recombinant human erythropoietin, or undergoing acute normovolemic hemodilution.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:控制组
安慰剂
|
麻醉诱导后给予安慰剂(生理盐水)
其他名称:
|
|
实验性的:Experimental group
ferric carboxymaltose 1000 mg
|
Ferric carboxymaltose is administered after anesthesia induction
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The changes of Hemoglobin between preoperative and postoperative day 30
大体时间:postoperative 30 days
|
intergroup-difference in hemoglobin change
|
postoperative 30 days
|
|
the changes of arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
大体时间:postoperative 5 days
|
intergroup-difference in PaO2/FiO2 ratio
|
postoperative 5 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
大体时间:postoperative 1 day
|
intergroup-difference in PaO2/FiO2 ratio
|
postoperative 1 day
|
|
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
大体时间:postoperative 3 days
|
intergroup-difference in PaO2/FiO2 ratio
|
postoperative 3 days
|
|
arterial oxygen tension/inspired oxygen (PaO2/FiO2 ratio)
大体时间:postoperative 5 days
|
intergroup-difference in PaO2/FiO2 ratio
|
postoperative 5 days
|
|
serum hemoglobin concentration
大体时间:postoperative 1 day
|
Intergroup difference of serum hemoglobin concentration, g/dL
|
postoperative 1 day
|
|
serum hemoglobin concentration
大体时间:postoperative 5 days
|
Intergroup difference of serum hemoglobin concentration, g/dL
|
postoperative 5 days
|
|
serum hemoglobin concentration
大体时间:postoperative 30 days
|
Intergroup difference of serum hemoglobin concentration, g/dL
|
postoperative 30 days
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.